121
Participants
Start Date
August 31, 2007
Primary Completion Date
April 30, 2009
Study Completion Date
May 31, 2009
Cobiprostone
18 mcg cobiprostone capsules for oral administration
Placebo
Matching placebo capsules for oral administration
Non-steroidal anti-inflammatory drug
Any marketed non-steroidal anti-inflammatory drug used by the participants as standard care.
Research Associates of New York, New York
Long Island Gastrointestinal Research Group, Great Neck
Altoona Center for Clinical Research, Duncansville
Gastroenterology Section at Temple University Hospital, Philadelphia
Digestive and Liver Disease Specialists, Norfolk
University of North Carolina Gastroenterology, Chapel Hill
University Clinical Research, Inc., Pembroke Pines
University of Illinois Medical Center, Chicago
Gulf Coast Research, LLC, Baton Rouge
Oklahoma Founddation for Digestive Research, Oklahoma City
Dallas VA Research Corporation, Inc., Dallas
Houston Institute for Clinical Research, Houston
Carl T Hayden VA Medical Center, Phoenix
Sepulveda Ambulatory Care Center, Sepulveda
Facey Medical Foundation, Mission Hills
Gregory J. Wiener, MD PC, Chula Vista
Desert Oasis Healthcare, Palm Springs
Loma Linda University Physicians Medical Group, Loma Linda
Boston Medical Center, Boston
Sucampo Pharma Americas, LLC
INDUSTRY